Neuro-Oncology: The Podcast

99 Episodes

1. CSF proteomics in glioma

   Published: 21/03/2025
2. Vorasidenib in IDH mutant glioma

   Published: 08/03/2025
3. KL-50 in post TMZ MMR-deficient GBM

   Published: 22/02/2025
4. Measurable disease per FET-PET vs MRI in GBM

   Published: 08/02/2025
5. Pre-radiation chemotherapy in GBM

   Published: 20/01/2025
6. cIMPACT-NOW Update 8: grading of meningiomas

   Published: 13/12/2024
7. Residual tumor volume and survival after CCNU/TMZ in GBM

   Published: 24/11/2024
8. Alterations in RNA splicing between meningioma DNA methylation groups

   Published: 08/11/2024
9. The immune landscape of IDH mutant and IDHwt glioma

   Published: 25/10/2024
10. Equity-driven applications of AI in neuro-oncology

    Published: 09/10/2024
11. IDH mutant glioma across age groups

    Published: 20/09/2024
12. Contemporary molecular prognostic signatures in glioma

    Published: 30/08/2024
13. FDG PET in PCNSL

    Published: 09/08/2024
14. TMZ and MGMT in elderly GBM patients

    Published: 12/07/2024
15. IDH mutant glioma and IDH inhibitors

    Published: 05/07/2024
16. Leptomeningeal disease, a SNO and ASCO review

    Published: 28/06/2024
17. Cancer stems cell in GBM

    Published: 21/06/2024
18. Drug delivery across the blood-brain barrier

    Published: 13/06/2024
19. Gliomatosis cerebri in children

    Published: 24/05/2024
20. Immunotherapy drives mesenchymal shift in GBM

    Published: 17/05/2024